Loading stock data…
HTFL
$28.67-1.09 (-3.66%)
Market ClosedLast close May 1
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide.
Historical Price
Price (Candle)
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$28.67
Potential Upside
5%
Whystock Fair Value$30.10
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus6 analysts
Buy
Mean target$37.67+31.4%
Range$35.00 – $43.00
Fundamentals
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personal...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.61B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-38.85%
Volume
Today's trading volume
1.28M
Recent News
A Look At HeartFlow (HTFL) Valuation As Investors Weigh Growth Hopes Against High P/S Multiple
Key metrics and recent trading context With no single headline event driving HeartFlow (HTFL) today, investors are likely focusing on its recent trading pattern, revenue and earnings profile, and the company’s position in non invasive coronary artery disease diagnostics. See our latest analysis for HeartFlow. The recent 1 day and 7 day share price returns of 2.56% and 2.87% sit against a 30 day share price return of 9.69% and a 5.07% year to date gain. This suggests momentum has been...
What Investors Should Know About One HeartFlow Insider's $2 Million Stock Sale
HeartFlow delivers AI-powered cardiac diagnostics to hospitals worldwide; a key insider recently trimmed their stake, SEC filings show.
Heartflow (HTFL) Soars 27% as Firm Guns For Double-Digit Growth
Heartflow Inc. (NASDAQ:HTFL) is one of the 10 Stocks Gaining Momentum Fast. Heartflow jumped by 26.99 percent week-on-week, as investors took heart from its double-digit revenue growth outlook for the year, supported by a strong performance in 2025. In an updated report earlier in the week, the company said that it grew its revenues by […]
Is HeartFlow Stock a Buy After Capricorn Investment Group Bought 1.7 Million Shares?
HeartFlow delivers AI-powered, non-invasive cardiac diagnostics to healthcare providers seeking advanced imaging and decision support tools.
HeartFlow Inc (HTFL) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...
HeartFlow Inc (HTFL) reports a 40% revenue increase and unveils new AI-driven tools, setting the stage for continued expansion and competitive advantage.